Home > Insider Trading > Filing (0001213900-20-037059)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733413	Tff Pharmaceuticals Inc.	TFFP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221451	Stephen Rocamboli	2600 Via Fortuna, Suite 360 Austin TX 78746		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-11-10	21,278	$2.50	21,278	No	4	M	Direct
Common Stock	Disposition	2020-11-10	21,278	$15.14	0	No	4	S	Direct
Common Stock	Acquisiton	2020-11-11	15,722	$2.50	15,722	No	4	M	Direct
Common Stock	Disposition	2020-11-11	15,722	$15.76	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2020-11-10	21,278	$0.00	21,278	$2.50
Common Stock	Stock Options (Right to Buy)	Disposition	2020-11-11	15,722	$0.00	15,722	$2.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
138,151	2019-09-26	2028-09-26	No	4	M	Direct
122,429	2019-09-26	2028-09-26	No	4	M	Direct

Footnotes

The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
23,003 shares of common stock vested on September 26, 2019 and the remainder of shares scheduled to vest at an approximate rate of 5,750 every three months thereafter.